Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Abivax (AAVXF) Assets Average (2022 - 2025)

Historic Assets Average for Abivax (AAVXF) over the last 3 years, with Q3 2025 value amounting to $448.9 million.

  • Abivax's Assets Average changed N/A to $448.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $448.9 million, marking a year-over-year change of. This contributed to the annual value of $286.5 million for FY2024, which is 3222.95% up from last year.
  • Latest data reveals that Abivax reported Assets Average of $448.9 million as of Q3 2025.
  • Over the past 5 years, Abivax's Assets Average peaked at $448.9 million during Q3 2025, and registered a low of $101.0 million during Q4 2022.
  • Moreover, its 3-year median value for Assets Average was $197.5 million (2025), whereas its average is $223.5 million.
  • The largest annual percentage gain for Abivax's Assets Average in the last 5 years was 11233.17% (2023), contrasted with its biggest fall of 11233.17% (2023).
  • Quarter analysis of 3 years shows Abivax's Assets Average stood at $101.0 million in 2022, then surged by 112.33% to $214.5 million in 2023, then skyrocketed by 109.27% to $448.9 million in 2025.
  • Its Assets Average was $448.9 million in Q3 2025, compared to $155.5 million in Q2 2025 and $197.5 million in Q1 2025.